Stocks making the biggest moves midday: DUOL, JBLU, TSLA, DHI

Stocks Making The Biggest Moves Midday Duol Jblu Tsla Dhi.jpeg

Check out the companies making headlines in midday trading. Duolingo — The online language app company popped 7.5% after JPMorgan reiterated its overweight rating on the stock, saying it has an attractive risk/reward and potential upside for its first-quarter guide and 2024 outlook. Taiwan Semiconductor Manufacturing — U.S.-traded shares of the Taiwanese chipmaker dropped 3.6% … Read more

Stocks making the biggest moves premarket: PVH, UNH, CVS

Stocks Making The Biggest Moves Premarket Pvh Unh Cvs.jpeg

Check out the companies making headlines before the bell. PVH — Shares of the Calvin Klein and Tommy Hilfiger parent tanked more than 21% on weak revenue guidance for the first quarter and full year. The retailer surpassed quarterly estimates on the top and bottom lines, but warned of a tougher macroeconomic setup and particular … Read more

RH, RDDT, EL, AMC and more

Rh Rddt El Amc And More.jpeg

Check out the companies making the biggest moves midday. RH — The luxury retailer surged 17.2% after offering strong full-year forecasts for demand and revenue growth. That allowed investors to look past a fourth-quarter earnings report that came in below expectations. Estée Lauder — Shares jumped more than 6% after Bank of America upgraded them … Read more

WBA, EL, ALL and more

Wba El All And More.jpeg

Check out the companies making headlines before the bell. Walgreens Boots Alliance — Shares dipped 1.6% after the company’s fiscal second quarter report was released. Walgreens generated $37.05 billion in revenue for the quarter, topping the LSEG forecast of $35.86 billon. However, the company also narrowed its full-year adjusted earnings guidance due in part to … Read more

NVDA, BA, SNAP, TSN and more

Nvda Ba Snap Tsn And More.jpeg

Check out the companies making headlines in midday trading. Nvidia — The chipmaker climbed nearly 5% and reached an all-time high after Goldman Sachs increased its price target to $800 per share from $625. Catalent , Novo Nordisk — The contract drug manufacturer climbed about 10% on the back of an agreement to get taken … Read more